High-activity mutants of butyrylcholinesterase for cocaine hydrolysis and method of generating the same
US-9206403-B1 · Dec 8, 2015 · US
US12371718B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12371718-B2 |
| Application number | US-202117198230-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 10, 2021 |
| Priority date | May 15, 2018 |
| Publication date | Jul 29, 2025 |
| Grant date | Jul 29, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are methods and compositions for catalytic glycolysis to deconstruct PET to bis(2-hydroxyethyl) terephthalate (BHET). For BHET conversion to terephthalate and ethylene glycol, we engineer Pseudomonas putida KT2440 with PETase and MHETase enzymes from Ideonella sakaiensis . We further engineer P. putida to convert terephthalate to a performance-advantaged bioproduct, β-ketoadipic acid, and for improved utilization of ethylene glycol, a byproduct of BHET catabolism. In a bioreactor, we produce 15.1±0.6 g/L of β-ketoadipic acid (βKA) from BHET at 76±3% molar yield. Lastly, we demonstrate conversion of catalytically depolymerized PET to βKA. Overall, this work highlights the potential of tandem catalytic deconstruction and biological conversion as a means to upcycle waste PET.
Opening claim text (preview).
What is claimed is: 1. A genetically modified Pseudomonas sp. organism, comprising: a nucleic acid sequence encoding a functional Ideonella sakaiensis PETase comprising a nucleic acid sequence encoding for a first secretion signal peptide; and a nucleic acid sequence encoding a functional Ideonella sakaiensis MHETase comprising a nucleic acid sequence encoding for a second secretion signal peptide; wherein the genetically modified organism metabolizes bis(2-hydroxyethyl) terephthalate (BHET) to produce BHET deconstruction products. 2. The genetically modified organism of claim 1 , wherein both nucleic acid sequences are codon optimized. 3. The genetically modified organism of claim 1 , wherein both nucleic acid sequences are incorporated into the genome of the genetically modified organism. 4. The genetically modified organism of claim 1 , wherein the nucleic acid sequence encoding a first secretion signal peptide encodes for a signal peptide with greater than 90% sequence identity to SEQ ID NO: 17; and wherein the nucleic acid sequence encoding for a second secretion signal peptide encodes for a signal peptide with greater than 90% sequence identity to SEQ ID NO: 19. 5. The genetically modified organism of claim 1 , wherein the organism is Pseudomonas putida. 6. The genetically modified organism of claim 1 , wherein the BHET deconstruction products comprise at least one of mono-(2-hydroxyethyl) terephthalate, terephthalate, ethylene glycol, ß-ketoadipate, or muconate. 7. A method comprising contacting poly (ethylene terephthalate) (PET) with the genetically modified organism of claim 1 to produce PET deconstruction products. 8. The method of claim 7 , wherein the contacting is performed in minimal salt medium.
Carboxylic ester hydrolases {(3.1.1)} · CPC title
Carboxylic ester hydrolases (3.1.1) · CPC title
polyhydric · CPC title
Polycarboxylic acids · CPC title
Recycling of unreacted starting or intermediate materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.